对用于癌症治疗的免疫检查点抑制剂进行全面的审查
1Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh.
International immunopharmacology
|October 24, 2024
概括
癌症免疫疗法使用免疫检查点抑制剂 (ICI) 通过释放免疫系统的车来准瘤. 本综述涵盖了ICI临床状态,生物标志物,耐药性和更好的癌症治疗不良事件.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌细胞通过利用免疫检查点来逃避免疫破坏,这些检查点通常会防止自身免疫.
- 针对PD-1/PD-L1,CTLA-4和LAG-3的免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗.
- 新兴的目标包括TIM-3,VISTA,B7-H3,BTLA和TIGIT,这表明免疫治疗正在进行的研究.
研究的目的:
- 为癌症治疗中免疫检查点抑制剂 (ICI) 提供全面的审查.
- 分析目前的临床状态,新兴生物标志物,耐药性机制和ICI的不良影响.
- 为优化ICI应用和改善瘤学患者治疗结果提供见解.
主要方法:
- 关于FDA批准和正在研究的ICI的当前临床状态的文献综述.
- 对生物标志物的分析 (例如PD-L1表达,瘤突变负担) 以预测ICI反应.
- 检查耐药机制和克服它们的策略,并评估与免疫相关的不良事件 (irAEs).
主要成果:
- 针对PD-1,PD-L1,CTLA-4和LAG-3的ICI在各种癌症中显示出显著的疗效.
- 生物标志物对于患者选择和预测ICI治疗反应至关重要.
- 挑战包括可变的患者益处和器官特异性免疫相关不良事件 (irAEs) 的发生.
结论:
- ICI代表了癌症免疫治疗的重大进步,为患者提供了新的希望.
- 了解生物标志物,耐药性和不良事件是最大限度地发挥ICI治疗潜力的关键.
- 对新的检查点和组合策略的持续研究对于推进癌症治疗至关重要.
更多相关视频
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
5.7K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cytotoxic T Cells-mediated Immune Response
853
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
853
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
